{
  "docId": "019de076-86c0-778c-b811-8ed1a345f3e4",
  "docSlug": "3a23784462a131093cb118313f70597a",
  "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
  "authorId": "neurobo-pharmaceuticals",
  "authorName": "NeuroBo Pharmaceuticals",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 4,
  "pageCount": 25,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 1,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-86c0-778c-b811-8ed1a345f3e4/4",
  "deckHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4",
  "deckJsonHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4.json",
  "deckAnchorHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.13,
        "w": 0.23,
        "x": 0.74,
        "y": 0.035
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5cdddd3c-d1e9-4ecb-bbfa-8320cfd908ed",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.46,
        "x": 0.078,
        "y": 0.57
      },
      "kind": "list",
      "text": "DA-1726: Submission of IND for Obesity in late December 2023",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "338ea601-17e3-4925-b80c-63a40adc7436",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.65,
        "x": 0.078,
        "y": 0.375
      },
      "kind": "list",
      "text": "DA-1241: Open IND for Treatment of MASH and Type 2 Diabetes; Actively recruiting into a Phase 2a for DA-1241 in subjects with presumed MASH; Completed SAD and MAD studies (in healthy volunteers and subjects with T2D)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a3cd508f-a2ad-4a13-953c-6722ea6bb69e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.52,
        "x": 0.058,
        "y": 0.78
      },
      "kind": "list",
      "text": "Exploring Strategic Opportunities to Out-License legacy assets",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ba9c051b-39b7-4c22-94df-45d75cb998d1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.49,
        "x": 0.058,
        "y": 0.68
      },
      "kind": "list",
      "text": "Backed by Strategic Partner and Major Shareholder, Dong-A ST",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ca667041-e64c-4c93-9485-e24c48f71d0b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.7,
        "x": 0.058,
        "y": 0.73
      },
      "kind": "list",
      "text": "Well Capitalized With $25.8 million in Cash at the end of Q3 2023. Cash runway into Q4 2024",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e5e90603-d202-4c26-88ad-c1c1bf05ec38",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.718,
        "x": 0.058,
        "y": 0.325
      },
      "kind": "list",
      "text": "Aiming to Increase Shareholder Value through Multiple, Near-Term, Value Creating Milestones",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f932ea47-7814-459a-a58f-1d6a7948bd4e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.786,
        "x": 0.058,
        "y": 0.228
      },
      "kind": "title",
      "text": "Targeting MASH and Obesity with a Pipeline of Next Generation Therapeutics",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ef580d5b-76ba-4b7c-9547-b87adfc70ea4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.065,
        "w": 0.553,
        "x": 0.058,
        "y": 0.048
      },
      "kind": "title",
      "text": "Compelling Investment Opportunity",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "15439ce1-9a85-4dc0-9755-91a5e4370cec",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Call to action",
      "slug": "call-to-action",
      "agent": null,
      "layer": "slide",
      "matchId": "ebb59558-64c1-4b36-9abb-9962a967196c",
      "evidence": "Aiming to Increase Shareholder Value through Multiple, Near-Term, Value Creating Milestones",
      "confidence": 0.7
    },
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "00282e3a-60cc-499c-8928-0363e52d400e",
      "evidence": "Targeting MASH and Obesity with a Pipeline of Next Generation Therapeutics",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 5,
      "from": 4,
      "beatId": "dbe82cfe-75f2-4785-9d67-d732f6043b6b",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Problem",
      "beatSlug": "sequoia-pitch-problem",
      "evidence": "Slides 4-5 discuss the target market and pipeline",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}